Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Cell-Free Fetal DNA Testing Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Cell-Free Fetal DNA Testing Market Status and Forecast (2016-2027)
      • 1.3.2 Global Cell-Free Fetal DNA Testing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Cell-Free Fetal DNA Testing Supply by Company

    • 2.1 Global Cell-Free Fetal DNA Testing Sales Value by Company
    • 2.2 Cell-Free Fetal DNA Testing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Cell-Free Fetal DNA Testing Market Status by Category

    • 3.1 Cell-Free Fetal DNA Testing Category Introduction
      • 3.1.1 Abnormal Chromosome Number Detection
      • 3.1.2 Gender Testing
      • 3.1.3 Paternally Inherited Disorder Detection
      • 3.1.4 Paternity testing
      • 3.1.5 Others
    • 3.2 Global Cell-Free Fetal DNA Testing Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Cell-Free Fetal DNA Testing Market Status by End User/Segment

    • 4.1 Cell-Free Fetal DNA Testing Segment by End User/Segment
      • 4.1.1 Hospital
      • 4.1.2 Clinic Center
    • 4.2 Global Cell-Free Fetal DNA Testing Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Cell-Free Fetal DNA Testing Market Status by Region

    • 5.1 Global Cell-Free Fetal DNA Testing Market by Region
    • 5.2 North America Cell-Free Fetal DNA Testing Market Status
    • 5.3 Europe Cell-Free Fetal DNA Testing Market Status
    • 5.4 Asia Pacific Cell-Free Fetal DNA Testing Market Status
    • 5.5 Central & South America Cell-Free Fetal DNA Testing Market Status
    • 5.6 Middle East & Africa Cell-Free Fetal DNA Testing Market Status

    6 North America Cell-Free Fetal DNA Testing Market Status

    • 6.1 North America Cell-Free Fetal DNA Testing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Cell-Free Fetal DNA Testing Market Status

    • 7.1 Europe Cell-Free Fetal DNA Testing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Cell-Free Fetal DNA Testing Market Status

    • 8.1 Asia Pacific Cell-Free Fetal DNA Testing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Cell-Free Fetal DNA Testing Market Status

    • 9.1 Central & South America Cell-Free Fetal DNA Testing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Cell-Free Fetal DNA Testing Market Status

    • 10.1 Middle East & Africa Cell-Free Fetal DNA Testing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Cell-Free Fetal DNA Testing Market Forecast by Category and by End User/Segment

    • 12.1 Global Cell-Free Fetal DNA Testing Sales Value Forecast (2022-2027)
    • 12.2 Global Cell-Free Fetal DNA Testing Forecast by Category
    • 12.3 Global Cell-Free Fetal DNA Testing Forecast by End User/Segment

    13 Global Cell-Free Fetal DNA Testing Market Forecast by Region/Country

    • 13.1 Global Cell-Free Fetal DNA Testing Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 The Fetal Medicine Centre
      • 14.1.1 Company Information
      • 14.1.2 Cell-Free Fetal DNA Testing Product Introduction
      • 14.1.3 The Fetal Medicine Centre Cell-Free Fetal DNA Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Sequenom Laboratories
      • 14.2.1 Company Information
      • 14.2.2 Cell-Free Fetal DNA Testing Product Introduction
      • 14.2.3 Sequenom Laboratories Cell-Free Fetal DNA Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Illumina, Inc.
      • 14.3.1 Company Information
      • 14.3.2 Cell-Free Fetal DNA Testing Product Introduction
      • 14.3.3 Illumina, Inc. Cell-Free Fetal DNA Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Arup Laboratories
      • 14.4.1 Company Information
      • 14.4.2 Cell-Free Fetal DNA Testing Product Introduction
      • 14.4.3 Arup Laboratories Cell-Free Fetal DNA Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Ariosa Diagnostics
      • 14.5.1 Company Information
      • 14.5.2 Cell-Free Fetal DNA Testing Product Introduction
      • 14.5.3 Ariosa Diagnostics Cell-Free Fetal DNA Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Apollo Path labs
      • 14.6.1 Company Information
      • 14.6.2 Cell-Free Fetal DNA Testing Product Introduction
      • 14.6.3 Apollo Path labs Cell-Free Fetal DNA Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis

    ...

      15 Conclusion

        16 Methodology

        Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Cell-Free Fetal DNA Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Cell-Free Fetal DNA Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

        Segmented by Category
        Abnormal Chromosome Number Detection
        Gender Testing
        Paternally Inherited Disorder Detection
        Paternity testing
        Others

        Segmented by End User/Segment
        Hospital
        Clinic Center

        Segmented by Country
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
        Central & South America
        Brazil
        Argentina
        Colombia
        Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

        Key manufacturers included in this survey
        The Fetal Medicine Centre
        Sequenom Laboratories
        Illumina, Inc.
        Arup Laboratories
        Ariosa Diagnostics
        Apollo Path labs
        Buy now